Akt, FoxO and regulation of apoptosis.

By Xinbo Zhang, N. Tang, T. Hadden, A. Rishi. Biochimica et Biophysica Acta, 2011

1,104 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/a7f139b473cd9a0a528eaaae90ba315929cef31e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Gautam Sethi
2. T. Balla
3. D. Fruman

In Oncology

1. T. Balla

Citations in the corpus

• Signal transduction in cancer. (2015, neutral): “4) (review Cagnol and Chambard 2010; Zhang et al. 2011).”
• Phosphoinositides: tiny lipids with giant impact on cell regulation. (2013, background): “Akt/ PKB have several downstream targets that are part of the cell survival pathway (860, 1620, 1806).”
• PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer (2023, background): “Indeed, in cancer, AKT can exert numerous important functions: 1) increases phosphorylation on BAD, thereby inhibiting apoptosis, and thus, increasing cell survival [126]; 2) enhances phosphorylation on IKKα, contributing to cell survival and proliferation [127]; 3) increases phosphorylation, and th”